For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
Making it simple is complicated
Wednesday 27 October 2021, 04:05 AM

The need for control seems to prevail among decision-makers [Brett Jordan on Unsplash]
Editor Barbara Fountain wonders why the powers that be don’t act on the partnership approach they espouse
You know how it is with GPs versus other specialists; well, welcome to the world of media hierarchy
Two current events illustrate the extremely p
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.